Covered recipient · General Payments record
ARTURO K GUILOFF
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$5,938.55
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,102.54 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| TELA Bio, Inc. | $403.71 | 5 |
| ABBVIE INC. | $237.02 | 15 |
| REVANCE THERAPEUTICS, INC. | $197.88 | 2 |
| Mentor Worldwide LLC | $140.84 | 1 |
| Musculoskeletal Transplant Foundation Inc. | $51.16 | 1 |
| Galderma Laboratories, L.P. | $43.35 | 2 |
| Dilon Technologies, Inc. | $28.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.01 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848798 | CMS |
| ABBVIE INC. | $2.33 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848800 | CMS |
| ABBVIE INC. | $16.96 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848802 | CMS |
| ABBVIE INC. | $6.15 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848804 | CMS |
| ABBVIE INC. | $21.30 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848806 | CMS |
| ABBVIE INC. | $25.13 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848808 | CMS |
| ABBVIE INC. | $2.75 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848810 | CMS |
| ABBVIE INC. | $5.80 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848812 | CMS |
| ABBVIE INC. | $1.93 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848814 | CMS |
| ABBVIE INC. | $58.40 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848816 | CMS |
| ABBVIE INC. | $27.15 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848818 | CMS |
| ABBVIE INC. | $7.96 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848820 | CMS |
| ABBVIE INC. | $17.59 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848822 | CMS |
| ABBVIE INC. | $18.29 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848824 | CMS |
| ABBVIE INC. | $5.27 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103848826 | CMS |
| Dilon Technologies, Inc. | $28.58 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112839007 | CMS |
| Galderma Laboratories, L.P. | $21.06 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301893 | CMS |
| Galderma Laboratories, L.P. | $22.29 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145301895 | CMS |
| Mentor Worldwide LLC | $140.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077609744 | CMS |
| Musculoskeletal Transplant Foundation Inc. | $51.16 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128569097 | CMS |
| REVANCE THERAPEUTICS, INC. | $129.76 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147919354 | CMS |
| REVANCE THERAPEUTICS, INC. | $68.12 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147919356 | CMS |
| TELA Bio, Inc. | $124.54 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164698 | CMS |
| TELA Bio, Inc. | $172.46 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164696 | CMS |
| TELA Bio, Inc. | $33.43 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164692 | CMS |
| TELA Bio, Inc. | $55.44 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164694 | CMS |
| TELA Bio, Inc. | $17.84 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154164690 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.